Lei Hao
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Journal: Frontiers in immunology
Published: January 02, 2026
Engineering RVG-modified exosomes for targeting TGF-β1 signaling in stroke recovery.
Journal: Journal of translational medicine
Published: December 26, 2025
α-lipoic acid nanoparticles functionalized with RVG29 peptide attenuate seizure-induced neurotoxicity by restoring mitochondrial homeostasis via the PINK1/Parkin pathway.
Journal: Free radical biology & medicine
Published: October 13, 2025
Application of efgartigimod in Chinese patients with myasthenia gravis: a single-center real-world prospective study.
Journal: Therapeutic advances in neurological disorders
Published: September 05, 2024
A case of X-Linked adrenoleukodystrophy caused by a novel mutation with singular clinical manifestation: unilateral lower limb weakness.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 06, 2024
Polyneuritis cranialis combined with Horner's syndrome: a rare variant of Guillain Barré syndrome.
Journal: BMC neurology
Published: May 11, 2024
A female adult-onset X-ALD patient with pure cerebellar symptoms:a case report.
Journal: Heliyon
Published: April 25, 2024
Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod.
Journal: Frontiers in immunology
Published: March 16, 2024
The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis.
Journal: CNS drugs
Published: January 08, 2024
Modulatory effects of mesenchymal stem cells on microglia in ischemic stroke.
Journal: Frontiers in neurology
Published: October 19, 2022
Last Updated: 09/26/2026